ChromaDex Corporation, a leading bioscience company developing products for healthy aging, operates through three segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The company's innovative research on nicotinamide adenine dinucleotide (NAD+) has led to the development and commercialization of proprietary-based ingredient technologies, including its flagship ingredient, NIAGEN. ChromaDex also offers finished dietary supplements containing its proprietary ingredients to consumers and distributors, as well as raw materials to manufacturers of consumer products. In addition, the company provides phytochemical reference standards and research and development services. ChromaDex distributes its TRU NIAGEN products directly to consumers through its proprietary e-commerce platform, TRUNIAGEN.com, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. With headquarters in Los Angeles, California, ChromaDex Corporation was founded in 1999.